ArticleAnnals of surgical oncology2024

Relatlimab, an Immune Checkpoint Inhibitor that Blocks LAG-3, the Latest Drug to be Added to the Arsenal of Systemic Therapies for Melanoma: What Does a Surgical Oncologist Need to Know?

Alexander C J van AkkooiPubMed ↗Publisher ↗

No numbers read from the abstract.